These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34009629)

  • 21. Telmisartan increases systemic exposure to rosuvastatin after single and multiple doses, and in vitro studies show telmisartan inhibits ABCG2-mediated transport of rosuvastatin.
    Hu M; Lee HK; To KK; Fok BS; Wo SK; Ho CS; Wong CK; Zuo Z; Chan TY; Chan JC; Tomlinson B
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1471-1478. PubMed ID: 27651239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
    Liu J; Yang W; Li Y; Wei Z; Dan X
    BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells.
    Susanto J; Lin YH; Chen YN; Shen CR; Yan YT; Tsai ST; Chen CH; Shen CN
    PLoS One; 2008; 3(12):e4023. PubMed ID: 19107196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial localization of ABC transporter ABCG2 and its function in 5-aminolevulinic acid-mediated protoporphyrin IX accumulation.
    Kobuchi H; Moriya K; Ogino T; Fujita H; Inoue K; Shuin T; Yasuda T; Utsumi K; Utsumi T
    PLoS One; 2012; 7(11):e50082. PubMed ID: 23189181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.
    Ueshima S; Hira D; Kimura Y; Fujii R; Tomitsuka C; Yamane T; Tabuchi Y; Ozawa T; Itoh H; Ohno S; Horie M; Terada T; Katsura T
    Br J Clin Pharmacol; 2018 Jun; 84(6):1301-1312. PubMed ID: 29457840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
    Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism.
    Mózner O; Bartos Z; Zámbó B; Homolya L; Hegedűs T; Sarkadi B
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human ABC transporters ABCG2 (BCRP) and ABCG4.
    Koshiba S; An R; Saito H; Wakabayashi K; Tamura A; Ishikawa T
    Xenobiotica; 2008 Jul; 38(7-8):863-88. PubMed ID: 18668433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
    Tian C; Ambrosone CB; Darcy KM; Krivak TC; Armstrong DK; Bookman MA; Davis W; Zhao H; Moysich K; Gallion H; DeLoia JA
    Gynecol Oncol; 2012 Mar; 124(3):575-81. PubMed ID: 22112610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
    Eckenstaler R; Benndorf RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells.
    Wu ZX; Mai Q; Yang Y; Wang JQ; Ma H; Zeng L; Chen ZS; Pan Y
    Biomed Pharmacother; 2021 Apr; 136():111223. PubMed ID: 33450491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and regulation of ABCG2/BCRP1 by sex steroids in the Harderian gland of the Syrian hamster (Mesocricetus auratus).
    Mares L; Vilchis F; Chávez B; Ramos L
    C R Biol; 2019; 342(9-10):279-289. PubMed ID: 31780416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.
    Dai Y; Liu S; Zhang WQ; Yang YL; Hang P; Wang H; Cheng L; Hsu PC; Wang YC; Xu Z; Jablons DM; You L
    Oncotarget; 2017 Jan; 8(3):4096-4109. PubMed ID: 27911857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-nucleotide polymorphisms in a short basic motif in the ABC transporter ABCG2 disable its trafficking out of endoplasmic reticulum and reduce cell resistance to anticancer drugs.
    Zhang W; Yang Y; Dong Z; Shi Z; Zhang JT
    J Biol Chem; 2019 Dec; 294(52):20222-20232. PubMed ID: 31719146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of
    Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
    [No Abstract]   [Full Text] [Related]  

  • 37. Common dysfunctional variants of ABCG2 have stronger impact on hyperuricemia progression than typical environmental risk factors.
    Nakayama A; Matsuo H; Nakaoka H; Nakamura T; Nakashima H; Takada Y; Oikawa Y; Takada T; Sakiyama M; Shimizu S; Kawamura Y; Chiba T; Abe J; Wakai K; Kawai S; Okada R; Tamura T; Shichijo Y; Akashi A; Suzuki H; Hosoya T; Sakurai Y; Ichida K; Shinomiya N
    Sci Rep; 2014 Jun; 4():5227. PubMed ID: 24909660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCG2 as a therapeutic target candidate for gout.
    Fujita K; Ichida K
    Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression.
    Zámbó B; Bartos Z; Mózner O; Szabó E; Várady G; Poór G; Pálinkás M; Andrikovics H; Hegedűs T; Homolya L; Sarkadi B
    Sci Rep; 2018 May; 8(1):7487. PubMed ID: 29749379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.